According to Bloomberg, NewLimit, a longevity startup founded by Coinbase co-founder Brian Armstrong, announced the completion of a $130 million Series B funding round, valuing the company at $810 million. This round is led by Kleiner Perkins, with other investors including Khodra Ventures and Human Capital. NewLimit aims to delay aging and restore cellular function by reprogramming specific proteins in human cells. It has raised a total of $275 million, including $105 million initially funded by the founder in 2021 and $40 million in 2023. https://www. (wublock123.com)/index.php? m=content&c=index&a=show&catid=6&id=42039